What move does the options market price into Immunic's report?

Implied ±20.7%, either direction.

IMUXNasdaqPharmaceutical Preparations

Immunic, Inc. (IMUX) earnings date, market-implied expected move, and options open interest by expiry

7.58

pre 7.58 +3.33%

Pre-market16:00 ETdelayed

Open7.53Volume166,969Mkt cap$103.7MEPS-2.62

Day7.53 – 7.7132%52-wk5.06 – 17.4320%

IMUX

Immunic, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±20.7%implied · straddle

6.039.17

spot 7.60exp Nov 20ATM strike 7.5ATM straddle 1.85IV 143%

Nov 3 close

Expected move

Inputs

Next report

Nov 12

before open · in 8 days

est.Q3 FY26

Calendar

Next report

Last report

+9.79%

vs ±18.3% implied · ×0.53

shaded = implied · ▲▼ = realized

Aug 11 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

Largest filed tie

13F top-10 QoQ

−87.35%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

57 managers

Top fund weight

0.00%

IMUX weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Immunic (IMUX) is expected to report on Nov 12 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 11 '26confirmed±18.3%▲+9.79%×0.53

quarterimplied−20%0+20%realized×

Q2 FY26±18.3%▲+9.79%×0.53

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 28 close

4.33OI · 3 expiries · Oct 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

610+6%

Positioning

Linked exposure

scenario · straddle±20.7%

Funds 1

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

GDP ×1.72· ±6.2% vs ±3.6% · 19 releases

eventrelease day|move|up · n×base

GDPgross domestic product±6.2%11 of 19×1.72

Immunic, Inc. (IMUX) earnings date, market-implied expected move, and options open interest by expiry

Implied vs realized

Implied vs realized

Positioning

Positioning

Linked exposure

Linked exposure

Revenue flow

Revenue flow

Intraday

Intraday

Event sensitivity

Implied vs realized

Positioning

Event sensitivity

Earnings history

Methodology

Immunic, Inc. (IMUX) earnings date, market-implied expected move, and options open interest by expiry

Intraday

Linked exposure

Revenue flow

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 11 '26 · confirmed	-0.80	—
Q1 FY26	—	-1.08	—
Q3 FY25	—	-0.13	—